GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	75.47	829.34	585.85	73.57	22.16
Cash & Short-Term Investments	75.47	829.34	585.85	73.57	22.16
Cash Growth	-90.90%	41.56%	696.36%	232.01%	-91.18%
Accounts Receivable	619.73	685.96	424.68	253.94	269.39
Other Receivables	50.34	23.89	318.64	408.81	221.5
Receivables	1,661	1,176	1,165	830.42	641.44
Inventory	945.21	695.27	485.89	500.45	456.05
Prepaid Expenses	-	-	-	17.58	20.46
Other Current Assets	183.55	164.7	216.65	126.47	143.34
Total Current Assets	2,865	2,866	2,454	1,548	1,283
Property, Plant & Equipment	641.17	572.14	548.11	540.21	476.53
Long-Term Investments	7.34	6.34	24.45	12.3	21.51
Goodwill	-	-	137.65	238.65	238.65
Long-Term Deferred Tax Assets	23.33	17.43	-	-	-
Other Long-Term Assets	115.83	96.48	21.33	85.09	97.2
Total Assets	3,653	3,558	3,185	2,425	2,117
Accounts Payable	486.93	524.53	176.8	104.54	49.28
Accrued Expenses	577.83	524.12	304.51	581.22	522.35
Short-Term Debt	-	-	-	118.21	145.73
Current Portion of Leases	38.28	28.39	17.48	29.52	-
Current Income Taxes Payable	159.39	97.93	308.57	17.38	1.23
Other Current Liabilities	313.45	348.98	585.89	161.22	170.56
Total Current Liabilities	1,576	1,524	1,393	1,012	889.15
Long-Term Leases	81.2	68.63	52.07	32.24	-
Long-Term Deferred Tax Liabilities	-	-	11.31	22.46	15.09
Total Liabilities	1,657	1,593	1,457	1,067	904.25
Common Stock	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,160	1,130	892.71	522.24	377.36
Total Common Equity	1,995	1,965	1,728	1,357	1,213
Minority Interest	0.6	0.6	0.58	0.58	0.59
Shareholders' Equity	1,996	1,965	1,728	1,358	1,213
Total Liabilities & Equity	3,653	3,558	3,185	2,425	2,117
Total Debt	119.48	97.03	69.55	179.97	145.73
Net Cash (Debt)	-44.01	732.32	516.3	-106.41	-123.58
Net Cash Growth	-	41.84%	-	-	-
Net Cash Per Share	-0.53	8.77	6.18	-1.27	-1.48
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51
Working Capital	1,289	1,342	1,060	536.41	394.3
Book Value Per Share	23.89	23.53	20.69	16.25	14.52
Tangible Book Value	1,995	1,965	1,590	1,119	973.85
Tangible Book Value Per Share	23.89	23.53	19.04	13.40	11.66
Land	17.59	17.59	12.65	12.65	12.65
Buildings	74.34	83.47	97.81	97.81	97.81
Machinery	696.44	668.83	662.18	629.59	571.91
Construction In Progress	152.54	108.51	88.86	98.67	122.98
Leasehold Improvements	24.27	26.81	26.85	42.34	42.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.